A report from the 27th Annual Congress Of The European Association Of Urology (February 24-28, 2012 - Paris, France).

IF 1.8 4区 医学 Q2 Medicine Drugs of today Pub Date : 2012-03-01 DOI:10.1358/dot.2012.48.3.1790306
X Rabasseda
{"title":"A report from the 27th Annual Congress Of The European Association Of Urology (February 24-28, 2012 - Paris, France).","authors":"X Rabasseda","doi":"10.1358/dot.2012.48.3.1790306","DOIUrl":null,"url":null,"abstract":"<p><p>Aging populations worldwide are already increasing the frequency of diseases of the urinary tract, including not just malignancies such as prostate and bladder cancer, but also common diseases of the aging male, such as benign prostatic hyperplasia, as well as age-facilitated diseases of women, such as urinary incontinence. Upon this background, the European Association of Urology (EAU) 2012 congress opened the gates in Paris, with attendees from across Europe and beyond crowding the Palais des Congres, as well as the subway lines leading to it. Four hectic days of oral and moderated poster sessions began, where leading scientists and researchers presented and discussed the results of clinical and preclinical research into many areas of urology related with the treatment and management of patients. The following report reviews many of these findings presented during the meeting, with a most direct impact on the current and future treatment for urological diseases.</p>","PeriodicalId":11397,"journal":{"name":"Drugs of today","volume":" ","pages":"233-43"},"PeriodicalIF":1.8000,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs of today","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1358/dot.2012.48.3.1790306","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aging populations worldwide are already increasing the frequency of diseases of the urinary tract, including not just malignancies such as prostate and bladder cancer, but also common diseases of the aging male, such as benign prostatic hyperplasia, as well as age-facilitated diseases of women, such as urinary incontinence. Upon this background, the European Association of Urology (EAU) 2012 congress opened the gates in Paris, with attendees from across Europe and beyond crowding the Palais des Congres, as well as the subway lines leading to it. Four hectic days of oral and moderated poster sessions began, where leading scientists and researchers presented and discussed the results of clinical and preclinical research into many areas of urology related with the treatment and management of patients. The following report reviews many of these findings presented during the meeting, with a most direct impact on the current and future treatment for urological diseases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
来自第27届欧洲泌尿外科协会年会上(2012年2月24-28日,法国巴黎)的一份报告。
世界范围内的老龄化人口已经增加了尿路疾病的发病率,不仅包括前列腺癌和膀胱癌等恶性肿瘤,还包括老年男性的常见疾病,如良性前列腺增生,以及老年女性易患的疾病,如尿失禁。在这样的背景下,2012年欧洲泌尿外科协会(EAU)大会在巴黎开幕,来自欧洲各地和其他地区的与会者挤满了会议宫,以及通往会议宫的地铁线路。为期四天的紧张的口头和主持海报会议开始了,在那里,领先的科学家和研究人员介绍和讨论了与患者治疗和管理相关的泌尿科许多领域的临床和临床前研究结果。以下报告回顾了会议期间提出的许多这些发现,对当前和未来泌尿系统疾病的治疗有最直接的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drugs of today
Drugs of today 医学-药学
CiteScore
3.90
自引率
0.00%
发文量
48
审稿时长
6-12 weeks
期刊介绍: An international, peer-reviewed journal publishing monographs on new products entering the market and review articles. Since its inception in 1965, Drugs of Today has established a reputation for excellence in providing physicians and other key healthcare professionals with practical, up-to-date monographs on recently approved and launched drugs.
期刊最新文献
Eldecalcitol for the treatment of osteoporosis. Linaclotide in the management of gastrointestinal tract disorders. Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder. Current status of treatment for chronic hepatitis C virus infection. A report from the 27th Annual Congress Of The European Association Of Urology (February 24-28, 2012 - Paris, France).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1